Fengli Hu

792 total citations
20 papers, 650 citations indexed

About

Fengli Hu is a scholar working on Molecular Biology, Epidemiology and Pathology and Forensic Medicine. According to data from OpenAlex, Fengli Hu has authored 20 papers receiving a total of 650 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Epidemiology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Fengli Hu's work include Autophagy in Disease and Therapy (5 papers), Image Retrieval and Classification Techniques (4 papers) and Cancer Mechanisms and Therapy (3 papers). Fengli Hu is often cited by papers focused on Autophagy in Disease and Therapy (5 papers), Image Retrieval and Classification Techniques (4 papers) and Cancer Mechanisms and Therapy (3 papers). Fengli Hu collaborates with scholars based in China and United States. Fengli Hu's co-authors include Bo Zhai, Jun Xu, Shangha Pan, Kai Li, Huihui Li, Yanli Zhang, Dali Zhao, Xueying Sun, Bo Zhai and Bing Liu and has published in prestigious journals such as PLoS ONE, Scientific Reports and RSC Advances.

In The Last Decade

Fengli Hu

18 papers receiving 647 citations

Peers

Fengli Hu

PFM

EPIDE

ONCOL

Dali Zhao China

Hyuk Moon South Korea

Shi Zuo China

Yuquan Tao China

Sandra Mattu Italy

Lindsey N. Jackson United States

Ming Lv China

Xiyan Xiang China

Katharina John Germany

Jingtao Zhong China

Dali Zhao China

Fengli Hu

431 ×1.2

143 ×0.8

PFM

153 ×1.0

EPIDE

293 ×2.2

143 ×1.1

ONCOL

Citations per year, relative to Fengli Hu Fengli Hu (= 1×) peers Dali Zhao

Countries citing papers authored by Fengli Hu

Since Specialization

Citations

This map shows the geographic impact of Fengli Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengli Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengli Hu more than expected).

Fields of papers citing papers by Fengli Hu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fengli Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengli Hu. The network helps show where Fengli Hu may publish in the future.

Co-authorship network of co-authors of Fengli Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Fengli Hu. A scholar is included among the top collaborators of Fengli Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fengli Hu. Fengli Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hu, Fengli, et al.. (2025). EGLN1 inhibition reverses angiogenesis impairment in hyperglycemia by activating autophagy. Scientific Reports. 15(1). 35804–35804.

Hu, Fengli, Ruixue Guo, Haijuan Hu, et al.. (2025). Exploring the key target molecules of angiogenesis in diabetic cardiomyopathy based on bioinformatics analysis. Frontiers in Endocrinology. 16. 1561142–1561142. 1 indexed citations

Li, Jingtao, Guocai Zhong, Fengli Hu, et al.. (2024). ASPH dysregulates cell death and induces chemoresistance in hepatocellular carcinoma. Cancer Letters. 611. 217396–217396. 4 indexed citations

Wang, Zongwen, et al.. (2023). Identification of risk and prognostic factors for intrahepatic vascular invasion in patients with hepatocellular carcinoma: a population-based study. Translational Cancer Research. 12(1). 93–112. 4 indexed citations

Chen, Yi, et al.. (2022). Astragalus polysaccharides combined with Codonopsis pilosula polysaccharides modulates the physiological characteristics of trophoblasts via miR-92a-1–5p/CCR7 axis. Tissue and Cell. 77. 101827–101827. 6 indexed citations

Hu, Fengli, et al.. (2020). PD-L1 monoclonal antibody-decorated nanoliposomes loaded with Paclitaxel and P-gp transport inhibitor for the synergistic chemotherapy against multidrug resistant gastric cancers. Nanoscale Research Letters. 15(1). 59–59. 30 indexed citations

Li, Xiaodong, et al.. (2020). Silencing <italic>KIF14</italic> reverses acquired resistance to sorafenib in hepatocellular carcinoma. Aging. 12(22). 22975–23003. 12 indexed citations

Li, Huihui, Fengli Hu, Yanli Zhang, & Kai Li. (2019). Comparative efficacy and acceptability of disease-modifying therapies in patients with relapsing–remitting multiple sclerosis: a systematic review and network meta-analysis. Journal of Neurology. 267(12). 3489–3498. 99 indexed citations

Hu, Fengli, et al.. (2019). The exogenous delivery of microRNA-449b-5p using spermidine-PLGA nanoparticles efficiently decreases hepatic injury. RSC Advances. 9(60). 35135–35144. 4 indexed citations

10.

Chen, Bingzhi, Junsheng Fu, Lei Zhang, et al.. (2017). Sexual life cycle of Volvariella volvacea revealed by investigation of the random migration of tetrad.. Mycosystema. 36(4). 466–472. 1 indexed citations

11.

Zhai, Bo, et al.. (2017). Activation of phosphatidylinositol 3-kinase/AKT/snail signaling pathway contributes to epithelial-mesenchymal transition-induced multi-drug resistance to sorafenib in hepatocellular carcinoma cells. PLoS ONE. 12(9). e0185088–e0185088. 86 indexed citations

12.

Hu, Fengli, et al.. (2015). Relativity between asymmetric nuclear division and strain degeneration in Volvariella volvacea.. Nanfang nongye xuebao. 46(3). 466–470. 1 indexed citations

13.

Zhai, Bo, Fengli Hu, Dali Zhao, et al.. (2015). Bufalin Reverses Resistance to Sorafenib by Inhibiting Akt Activation in Hepatocellular Carcinoma: The Role of Endoplasmic Reticulum Stress. PLoS ONE. 10(9). e0138485–e0138485. 46 indexed citations

14.

Zhai, Bo, Fengli Hu, Xian Jiang, et al.. (2014). Inhibition of Akt Reverses the Acquired Resistance to Sorafenib by Switching Protective Autophagy to Autophagic Cell Death in Hepatocellular Carcinoma. Molecular Cancer Therapeutics. 13(6). 1589–1598. 245 indexed citations

15.

Hu, Fengli, et al.. (2013). Blocking autophagy enhances the apoptosis effect of bufalin on human hepatocellular carcinoma cells through endoplasmic reticulum stress and JNK activation. APOPTOSIS. 19(1). 210–223. 68 indexed citations

16.

Wang, Dong, et al.. (2012). High YKL-40 Serum Concentration Is Correlated with Prognosis of Chinese Patients with Breast Cancer. PLoS ONE. 7(12). e51127–e51127. 26 indexed citations

17.

Hu, Fengli. (2007). Robust Color Histogram Image Retrieval Based on Bit-plane. Journal of Chinese Computer Systems. 1 indexed citations

18.

Hu, Fengli. (2007). A Robust Color Image Retrieval Based on Significant Bit-plane. 1 indexed citations

19.

Wang, Xiangyang, Hongying Yang, & Fengli Hu. (2006). A new regions-of-interest based image retrieval using DWT. 1. 127–130. 4 indexed citations

20.

Wang, Xiangyang, Fengli Hu, & Hongying Yang. (2006). A Novel Regions-of-Interest Based Image Retrieval Using Multiple Features. 24. 377–380. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact